Payment overview · 2025
General Payments
$86.76
1 reported records · 1 companies
Healthcare provider profile · identity verified
Tina Michelle Compton, FNP
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · GRUNDY, VA · NPI 1700940327
Verified facts
What the public records show
CMS Open Payments records show Tina Michelle Compton, FNP received $86.76 in general payments during 2025 across 1 reported records.
Otsuka America Pharmaceutical, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $86.76 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $86.76 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $86.76 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 1093 | 123 |
| Gabapentin | Gabapentin | 861 | 107 |
| Levothyroxine Sodium | Levothyroxine Sodium | 347 | 73 |
| Losartan Potassium | Losartan Potassium | 335 | 73 |
| Omeprazole | Omeprazole | 310 | 64 |
| Metformin Hcl | Metformin Hcl | 298 | 60 |
| Atorvastatin Calcium | Atorvastatin Calcium | 290 | 76 |
| Pantoprazole Sodium | Pantoprazole Sodium | 265 | 65 |
| Hydrochlorothiazide | Hydrochlorothiazide | 244 | 54 |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 227 | 66 |
| Alprazolam | Alprazolam | 227 | 29 |
| Montelukast Sodium | Montelukast Sodium | 223 | 56 |
| Simvastatin | Simvastatin | 215 | 50 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 205 | 44 |
| Lisinopril | Lisinopril | 204 | 54 |
| Prednisone | Prednisone | 202 | 118 |
| Amlodipine Besylate | Amlodipine Besylate | 172 | 36 |
| Tramadol Hcl | Tramadol Hcl | 164 | 26 |
| Lorazepam | Lorazepam | 159 | 23 |
| Sertraline Hcl | Sertraline Hcl | 156 | 38 |
| Diclofenac Sodium | Diclofenac Sodium | 154 | 30 |
| Azithromycin | Azithromycin | 151 | 103 |
| Furosemide | Furosemide | 147 | 40 |
| Tamsulosin Hcl | Tamsulosin Hcl | 145 | 34 |
| Pravastatin Sodium | Pravastatin Sodium | 143 | 31 |
| Eliquis | Apixaban | 126 | 20 |
| Metoprolol Tartrate | Metoprolol Tartrate | 126 | 31 |
| Baclofen | Baclofen | 122 | 30 |
| Fluticasone Propionate | Fluticasone Propionate | 114 | 26 |
| Buspirone Hcl | Buspirone Hcl | 113 | 24 |
| Ibuprofen | Ibuprofen | 106 | 28 |
| Potassium Chloride | Potassium Chloride | 101 | 29 |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 100 | 68 |
| Metoprolol Succinate | Metoprolol Succinate | 98 | 27 |
| Meloxicam | Meloxicam | 97 | 25 |
| Mounjaro | Tirzepatide | 94 | 14 |
| Duloxetine Hcl | Duloxetine Hcl | 93 | 24 |
| Atenolol | Atenolol | 91 | 19 |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 89 | 17 |
| Citalopram Hbr | Citalopram Hydrobromide | 85 | 15 |
| Sucralfate | Sucralfate | 84 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 83 | 13 |
| Zolpidem Tartrate | Zolpidem Tartrate | 82 | 12 |
| Glipizide | Glipizide | 80 | 19 |
| Clopidogrel | Clopidogrel Bisulfate | 79 | 21 |
| Clonazepam | Clonazepam | 77 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 77 | 16 |
| Dexlansoprazole Dr | Dexlansoprazole | 76 | 13 |
| Celecoxib | Celecoxib | 75 | 18 |
| Ventolin Hfa | Albuterol Sulfate | 74 | 18 |
| Fenofibrate | Fenofibrate Nanocrystallized | 73 | 15 |
| Ozempic | Semaglutide | 73 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 71 | 16 |
| Carvedilol | Carvedilol | 70 | 17 |
| Levocetirizine Dihydrochloride | Levocetirizine Dihydrochloride | 68 | 15 |
| Synthroid | Levothyroxine Sodium | 67 | 14 |
| Famotidine | Famotidine | 65 | 14 |
| Oxycodone-Acetaminophen | Oxycodone Hcl/Acetaminophen | 64 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 64 | 14 |
| Lansoprazole | Lansoprazole | 63 | 13 |
| Amoxicillin | Amoxicillin | 62 | 29 |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 62 | suppressed |
| Warfarin Sodium | Warfarin Sodium | 59 | 11 |
| Spironolactone | Spironolactone | 58 | suppressed |
| Allopurinol | Allopurinol | 57 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 54 | 16 |
| Trazodone Hcl | Trazodone Hcl | 54 | suppressed |
| Fluconazole | Fluconazole | 53 | 24 |
| Tizanidine Hcl | Tizanidine Hcl | 50 | 11 |
| Pregabalin | Pregabalin | 49 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 48 | 13 |
| Escitalopram Oxalate | Escitalopram Oxalate | 48 | 11 |
| Ezetimibe | Ezetimibe | 48 | 17 |
| Butalbital-Acetaminophen-Caffe | Butalb/Acetaminophen/Caffeine | 47 | suppressed |
| Glipizide Er | Glipizide | 47 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 47 | 15 |
| Alendronate Sodium | Alendronate Sodium | 43 | suppressed |
| Trulicity | Dulaglutide | 43 | suppressed |
| Nitroglycerin | Nitroglycerin | 42 | 21 |
| Mirtazapine | Mirtazapine | 41 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 40 | 13 |
| Fluoxetine Hcl | Fluoxetine Hcl | 39 | suppressed |
| Cyanocobalamin Injection | Cyanocobalamin (Vitamin B-12) | 38 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 38 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 38 | suppressed |
| Topiramate | Topiramate | 38 | suppressed |
| Linzess | Linaclotide | 36 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 34 | 11 |
| Ondansetron Odt | Ondansetron | 34 | 14 |
| Dicyclomine Hcl | Dicyclomine Hcl | 33 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 33 | suppressed |
| Sildenafil Citrate | Sildenafil Citrate | 32 | suppressed |
| Finasteride | Finasteride | 31 | suppressed |
| Lactulose | Lactulose | 30 | suppressed |
| Naproxen | Naproxen | 30 | suppressed |
| Januvia | Sitagliptin Phosphate | 29 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 28 | 17 |
| Chlorthalidone | Chlorthalidone | 28 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 28 | suppressed |
| Fenofibrate | Fenofibrate | 27 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 27 | suppressed |
| Vascepa | Icosapent Ethyl | 27 | suppressed |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 26 | suppressed |
| Ibandronate Sodium | Ibandronate Sodium | 26 | suppressed |
| Hydrocortisone | Hydrocortisone | 25 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 25 | suppressed |
| Temazepam | Temazepam | 25 | suppressed |
| Gemfibrozil | Gemfibrozil | 24 | suppressed |
| Glimepiride | Glimepiride | 23 | suppressed |
| Diclofenac Potassium | Diclofenac Potassium | 22 | suppressed |
| Estradiol | Estradiol | 22 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 22 | 14 |
| Tresiba Flextouch U-200 | Insulin Degludec | 22 | suppressed |
| Cephalexin | Cephalexin | 20 | 12 |
| Fenofibrate | Fenofibrate,micronized | 20 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 20 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 19 | suppressed |
| Azelastine Hcl | Azelastine Hcl | 19 | suppressed |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 19 | suppressed |
| Diazepam | Diazepam | 19 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 19 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 19 | suppressed |
| Bupropion Xl | Bupropion Hcl | 18 | suppressed |
| Dropsafe Prep Pads | Alcohol Antiseptic Pads | 18 | suppressed |
| Levofloxacin | Levofloxacin | 18 | 12 |
| Lidocaine | Lidocaine | 18 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 18 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 18 | suppressed |
| Amlodipine Besylate-Benazepril | Amlodipine Besylate/Benazepril | 17 | suppressed |
| Loperamide | Loperamide Hcl | 17 | suppressed |
| Valsartan | Valsartan | 16 | suppressed |
| Diclofenac Sodium Er | Diclofenac Sodium | 15 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 15 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 15 | suppressed |
| Glyburide | Glyburide | 15 | suppressed |
| Methocarbamol | Methocarbamol | 15 | suppressed |
| Nebivolol Hcl | Nebivolol Hcl | 15 | suppressed |
| Novolin 70-30 | Insulin Nph Hum/Reg Insulin Hm | 15 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 15 | suppressed |
| Testosterone Cypionate | Testosterone Cypionate | 15 | suppressed |
| Alcohol Pads | Alcohol Antiseptic Pads | 14 | suppressed |
| Bumetanide | Bumetanide | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Insulin Syringe | Syringe And Needle,insulin,1ml | 14 | suppressed |
| Levetiracetam | Levetiracetam | 14 | suppressed |
| Nystatin | Nystatin | 14 | 11 |
| Quetiapine Fumarate | Quetiapine Fumarate | 14 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 14 | suppressed |
| Acyclovir | Acyclovir | 13 | suppressed |
| Asa-Butalb-Caffeine-Codeine | Codeine/Butalbital/Asa/Caffein | 13 | suppressed |
| Captopril | Captopril | 13 | suppressed |
| Humulin R | Insulin Regular, Human | 13 | suppressed |
| Indapamide | Indapamide | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Mupirocin | Mupirocin | 13 | suppressed |
| Olanzapine | Olanzapine | 13 | suppressed |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 13 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 13 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 12 | suppressed |
| Droplet Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Erythromycin | Erythromycin Base | 12 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Glipizide-Metformin | Glipizide/Metformin Hcl | 12 | suppressed |
| Hydrocodone-Ibuprofen | Hydrocodone/Ibuprofen | 12 | suppressed |
| Megestrol Acetate | Megestrol Acetate | 12 | suppressed |
| Movantik | Naloxegol Oxalate | 12 | suppressed |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 12 | suppressed |
| Sulfasalazine | Sulfasalazine | 12 | suppressed |
| Ultra-Fine Nano Pen Needle | Pen Needle, Diabetic | 12 | suppressed |
| Vraylar | Cariprazine Hcl | 12 | suppressed |
| Wegovy | Semaglutide | 12 | suppressed |
| Desloratadine | Desloratadine | 11 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 11 | suppressed |
| Droplet Insulin Syringe | Syringe And Needle,insulin,1ml | 11 | suppressed |
| Enalapril-Hydrochlorothiazide | Enalapril/Hydrochlorothiazide | 11 | suppressed |
| Ofloxacin | Ofloxacin | 11 | suppressed |
| Tegretol Xr | Carbamazepine | 11 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Verapamil Er | Verapamil Hcl | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $86.76 · 1 records | Otsuka America Pharmaceutical, Inc. | REXULTI | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error